Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation

In patients with chronic lymphocytic leukemia (CLL), persistence of disease after allogeneic stem cell transplantation (alloSCT) can result in poor outcomes. In an effort to improve these outcomes, patients with persistent CLL who were 90–100 days post alloSCT with no evidence of graft-versus-host-d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Khouri, Maria R., Jabbour, Elias J., Gulbis, Alison M., Turturro, Francesco, Ledesma, Celina, Korbling, Martin, Samuels, Barry I., Ahmed, Sairah, Alousi, Amin M., Ciurea, Stefan O., Marin, David, Patel, Krina K., Popat, Uday R., Bueso-Ramos, Carlos E., Bassett, Roland L., Khouri, Issa F.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141702/
https://ncbi.nlm.nih.gov/pubmed/28495642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars